LENZ LENZ Therapeutics, Inc. - Common Stock
$6,81
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 11, 2026
Zakres 52 tyg.
$7–$50
0% of range
Ocena Analityków
STRONG BUY
13 analysts
Cena Docelowa
$32
+370% upside
P/E (TTM)
-5.6
ROE
-33.5%
Marża Zysku Netto
-430.2%
LENZ Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$6.80
Kapitalizacja Rynkowa
$502M
P/E (TTM)
-5.6
EPS (TTM)
$-2.85
Przychody (TTM)
$19M
Stopa dywidendy
—
ROE
-33.5%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$7 – $50
LENZ Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$19M
2024-12-31
→
2025-12-31
EPS
$-2.85
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-70M
2021-12-31
→
2025-12-31
Marże
-430.2%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
LENZ
Mediana porównawcza
P/E (TTM)
-5.6
5.9
P/S (TTM)
26.3
13.3
P/B
1.8
1.9
Price / FCF (Cena / FCF)
-7.2
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
LENZ
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-477.5%
—
Net Profit Margin (Marża Zysku Netto)
-430.2%
31.7%
ROA
-31.5%
-3.7%
ROE
-33.5%
-0.77%
ROIC
-32.2%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
LENZ
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
14.2
8.8
Quick Ratio (Wskaźnik Szybkości)
1.2
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
LENZ
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
LENZ
Mediana porównawcza
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy
—
Wskaźnik Wypłaty Dywidendy
—
CAGR dywidendy 5-letni
—
| Data ex-dywidendy | Kwota |
|---|---|
| 22 marca 2024 | $7,2100 |
| 15 marca 2024 | $7,2100 |
LENZ Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
13 analityków
- Mocne kupno 6 46,2%
- Kup 6 46,2%
- Trzymaj 1 7,7%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
Średnia cel
$32.00
+370,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.03%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-1.32 | $-1.09 | -0.23% |
| 31 grudnia 2025 | $-1.16 | $-0.99 | -0.17% |
| 30 września 2025 | $-0.59 | $-0.72 | 0.13% |
| 30 czerwca 2025 | $-0.51 | $-0.62 | 0.11% |
| 31 marca 2025 | $-0.53 | $-0.56 | 0.03% |
| 31 grudnia 2024 | $-0.46 | $-0.42 | -0.04% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| CNTX | $135M | -3.9 | 112.7% | — | -50.5% | — |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| PLYX | — | — | — | — | -193.7% | — |
| ASRT | $58M | -1.9 | -5.0% | -25.6% | -32.4% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $19M | $0 | |
| Cost of Revenue | $418.0K | $0 | |
| R&D Expense | $19M | $30M | |
| SG&A Expense | $91M | $29M | |
| Operating Expenses | $110M | $59M | |
| Operating Income | $-91M | $-59M | |
| Interest Income | $10M | $9M | |
| Other Non-op | $-243.0K | $289.0K | |
| Pretax Income | $-82M | $-50M | |
| Income Tax | $502.0K | $1.0K | |
| Net Income | $-82M | $-50M | |
| EPS (Basic) | $-2.85 | $-2.34 | |
| EPS (Diluted) | $-2.85 | $-2.34 | |
| Shares (Basic) | 28,813,164 | 21,281,038 | |
| Shares (Diluted) | 28,813,164 | 21,281,038 | |
| EBITDA | $-91M | $-59M |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $25M | $20M | |
| Receivables | $329.0K | $0 | |
| Inventory | $3M | $0 | |
| Prepaid Expense | $6M | $3M | |
| Current Assets | $301M | $212M | |
| PP&E (Net) | $1M | $651.0K | |
| PP&E (Gross) | $2M | $719.0K | |
| Accum. Depreciation | $355.0K | $68.0K | |
| Other Non-current Assets | $3M | $1M | |
| Total Assets | $306M | $215M | |
| Accounts Payable | $4M | $4M | |
| Accrued Liabilities | $17M | $6M | |
| Current Liabilities | $21M | $10M | |
| Capital Leases | $350.0K | $814.0K | |
| Other Non-current Liabilities | · | $0 | |
| Total Liabilities | $22M | $11M | |
| Common Stock | $1.0K | $1.0K | |
| Paid-in Capital | $511M | $349M | |
| Retained Earnings | $-227M | $-145M | |
| AOCI | $242.0K | $196.0K | |
| Stockholders' Equity | $284M | $204M | |
| Liabilities + Equity | $306M | $215M | |
| Shares Outstanding | 31,344,782 | 27,518,439 |
Przepływy pieniężne 13
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $287.0K | $58.0K | |
| Stock-based Comp | $13M | $6M | |
| Deferred Tax | $0 | $0 | |
| Other Non-cash | $123.0K | $-16M | |
| Operating Cash Flow | $-69M | $-59M | |
| CapEx | $827.0K | $468.0K | |
| Investing Cash Flow | $-76M | $-154M | |
| Stock Issued | · | $80M | |
| Net Stock Activity | · | $80M | |
| Financing Cash Flow | $150M | $199M | |
| Net Change in Cash | $5M | $-15M | |
| Taxes Paid | $502.0K | · | |
| Free Cash Flow | $-70M | $-60M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -477.5% | · | |
| Net Margin | -430.2% | · | |
| Pretax Margin | -427.6% | · | |
| EBITDA Margin | -476.0% | · | |
| ROA | -31.5% | -34.8% | |
| ROE | -33.5% | -23.7% | |
| ROIC | -32.2% | -28.7% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 14.2 | 20.4 | |
| Quick Ratio | 1.2 | 1.9 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | · | |
| Inventory Turnover | 0.3 | · | |
| Receivables Turnover | 116.0 | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $19M | $0 | |
| Net Income TTM | $-82M | $-50M | |
| Market Cap | $502M | $794M | |
| P/E | -5.6 | -12.3 | |
| P/S | 26.3 | · | |
| P/B | 1.8 | 3.9 | |
| P / Tangible Book | 1.8 | 3.9 | |
| P / Cash Flow | -7.3 | -13.4 | |
| P / FCF | -7.2 | -13.3 | |
| Earnings Yield | -17.8% | -8.1% |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $12M | $5M | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $1M | · | · | · | $0 | · | · | · | |
| R&D Expense | $0 | $0 | $4M | $9M | $6M | $6M | $6M | $7M | |
| SG&A Expense | $45M | $40M | $28M | $13M | $11M | $9M | $6M | $7M | |
| Operating Expenses | $46M | $40M | $31M | $22M | $17M | $15M | $13M | $14M | |
| Operating Income | $-44M | $-38M | $-19M | $-17M | $-17M | $-15M | $-13M | $-14M | |
| Interest Income | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | |
| Other Non-op | $3.0K | $-417.0K | $-14.0K | $199.0K | $-11.0K | $8.0K | $-6.0K | $2M | |
| Pretax Income | · | $-36M | $-17M | $-14M | · | $-13M | $-10M | $-10M | |
| Income Tax | · | $2.0K | $0 | $500.0K | · | $1.0K | $0 | $0 | |
| Net Income | $-41M | $-36M | $-17M | $-15M | $-15M | $-13M | $-10M | $-10M | |
| EPS (Basic) | $-1.32 | $-1.20 | $-0.59 | $-0.53 | $-0.53 | $1.97 | $-0.38 | $-0.40 | |
| EPS (Diluted) | $-1.32 | $-1.20 | $-0.59 | $-0.53 | $-0.53 | $1.97 | $-0.38 | $-0.40 | |
| Shares (Basic) | 31,352,702 | -55,332,525 | 28,540,519 | 28,079,071 | 27,526,099 | -36,217,499 | 27,172,330 | 25,608,594 | |
| Shares (Diluted) | 31,352,702 | -55,332,525 | 28,540,519 | 28,079,071 | 27,526,099 | -36,217,499 | 27,172,330 | 25,608,594 | |
| EBITDA | $-44M | · | $-19M | $-17M | $-17M | · | $-13M | $-14M |
Bilans 23
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $25M | $25M | $38M | $23M | $20M | $41M | $84M | |
| Receivables | $343.0K | $329.0K | · | · | · | $0 | · | · | |
| Inventory | $3M | $3M | $949.0K | · | · | $0 | · | · | |
| Prepaid Expense | $6M | $6M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Current Assets | $268M | $301M | $207M | $214M | $198M | $212M | $221M | $199M | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $926.0K | $651.0K | $372.0K | $164.0K | |
| PP&E (Gross) | · | $2M | · | · | · | $719.0K | · | · | |
| Accum. Depreciation | · | $355.0K | · | · | · | $68.0K | · | · | |
| Other Non-current Assets | $2M | $3M | $2M | $2M | $1M | $1M | $1M | $1M | |
| Total Assets | $273M | $306M | $211M | $217M | $201M | $215M | $224M | $203M | |
| Accounts Payable | $11M | $4M | $4M | $3M | $4M | $4M | $3M | $4M | |
| Accrued Liabilities | $15M | $17M | $12M | $8M | $5M | $6M | $5M | $4M | |
| Current Liabilities | $26M | $21M | $16M | $10M | $9M | $10M | $8M | $9M | |
| Capital Leases | $237.0K | $350.0K | $461.0K | $569.0K | $673.0K | $814.0K | $953.0K | $1M | |
| Other Non-current Liabilities | · | · | · | · | · | · | $64.0K | $83.0K | |
| Total Liabilities | $26M | $22M | $17M | $11M | $9M | $11M | $9M | $10M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | |
| Paid-in Capital | $516M | $511M | $385M | $381M | $352M | $349M | $347M | $315M | |
| Retained Earnings | $-269M | $-227M | $-191M | $-175M | $-160M | $-145M | $-132M | $-122M | |
| AOCI | $-450.0K | $242.0K | $227.0K | $38.0K | $123.0K | $196.0K | $523.0K | $-62.0K | |
| Stockholders' Equity | $246M | $284M | $194M | $206M | $192M | $204M | $215M | $193M | |
| Liabilities + Equity | $273M | $306M | $211M | $217M | $201M | $215M | $224M | $203M | |
| Shares Outstanding | 31,354,394 | 31,344,782 | 28,588,261 | 28,500,122 | 27,535,663 | 27,518,439 | 27,480,634 | 25,845,671 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $111.0K | $107.0K | $125.0K | $19.0K | $36.0K | $25.0K | $10.0K | $18.0K | |
| Stock-based Comp | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-cash | $3M | · | · | · | $-4M | · | · | · | |
| Operating Cash Flow | $-34M | $-33M | $-9M | $-12M | $-16M | $-9M | $-11M | $-16M | |
| CapEx | $18.0K | $38.0K | $439.0K | $240.0K | $110.0K | $149.0K | $186.0K | $133.0K | |
| Investing Cash Flow | $33M | $-90M | $-4M | $-414.0K | $19M | $-12M | $-62M | $-98M | |
| Stock Issued | · | · | · | · | $0 | · | $30M | $-4M | |
| Net Stock Activity | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $14.0K | $123M | $598.0K | $26M | $44.0K | $53.0K | $30M | $-2M | |
| Net Change in Cash | $-407.0K | $-220.0K | $-12M | $15M | $3M | $-21M | $-43M | $-116M | |
| Free Cash Flow | $-34M | · | · | · | $-16M | · | · | · |
Rentowność 7
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2321.7% | · | -151.1% | -337.1% | · | · | · | · | |
| Net Margin | -2182.4% | · | -133.6% | -298.2% | · | · | · | · | |
| Pretax Margin | · | · | -133.6% | -288.2% | · | · | · | · | |
| EBITDA Margin | -2315.8% | · | -151.1% | -337.1% | · | · | · | · | |
| ROA | -17.5% | · | -7.7% | -7.1% | -7.0% | · | -4.2% | -4.2% | |
| ROE | -18.9% | · | -8.2% | -7.5% | -7.5% | · | -4.9% | -4.9% | |
| ROIC | · | · | -9.7% | -8.5% | · | · | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.4 | · | 12.7 | 20.5 | 23.1 | · | 28.6 | 23.2 | |
| Quick Ratio | 1.0 | · | 1.6 | 3.6 | 2.7 | · | 5.3 | 9.8 |
Efektywność 3
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.1 | 0.0 | · | · | · | · | |
| Inventory Turnover | 0.6 | · | · | · | · | · | · | · | |
| Receivables Turnover | 11.1 | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | · | · | · | · | · | · | · | |
| Net Income TTM | $-88M | · | $-56M | $-50M | $-52M | · | $-56M | $-61M | |
| Market Cap | $287M | · | $1.33B | $835M | $708M | · | $652M | $447M | |
| P/E | -3.1 | · | -22.9 | -15.9 | -5.3 | · | -1.7 | -0.8 | |
| P/S | 14.8 | · | · | · | · | · | · | · | |
| P/B | 1.2 | · | 6.9 | 4.0 | 3.7 | · | 3.0 | 2.3 | |
| P / Tangible Book | 1.2 | · | 6.9 | 4.0 | 3.7 | · | 3.0 | 2.3 | |
| P / Cash Flow | -8.5 | · | · | · | -44.1 | · | · | · | |
| P / FCF | -8.5 | · | · | · | -43.8 | · | · | · | |
| Earnings Yield | -32.5% | · | -4.4% | -6.3% | -18.8% | · | -58.7% | -121.9% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $19M | $0 | — | — | — |
| Marża Operacyjna % | -477.5% | — | — | — | — |
| Zysk netto | $-82M | $-50M | $-70M | $-101M | $-71M |
| Rozwodniony EPS | $-2.85 | $-2.34 | $-35.71 | $-1.84 | $-2.45 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 14.2 | 20.4 | 39.2 | — | 31.4 |
| Wskaźnik Szybkości | 1.2 | 1.9 | 38.4 | — | 31.0 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-70M | $-60M | $-101M | — | $-59M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.